Galera Therapeutics's market cap is currently $3.28M. The company's EPS TTM is $-0.36; its P/E ratio is ―; Galera Therapeutics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -259.00K	$ -114.00K	$ -778.00K	$ -368.00K	$ -267.00K
Operating Income	$ -46.95M	$ -51.23M	$ -73.37M	$ -70.55M	$ -50.69M
EBITDA	$ -46.69M	$ -50.61M	$ -72.56M	$ -69.01M	$ -50.69M
Net Income	$ -59.08M	$ -62.22M	$ -87.73M	$ -74.22M	$ -51.93M
Balance Sheet
Cash & Short-Term Investments	$ 18.26M	$ 31.60M	$ 71.22M	$ 72.78M	$ 112.29M
Total Assets	$ 26.14M	$ 44.04M	$ 83.31M	$ 84.10M	$ 123.38M
Total Debt	$ 1.25M	$ 44.00K	$ 302.00K	$ 534.00K	$ 831.00K
Net Debt	$ -17.01M	$ -4.22M	$ -19.56M	$ -15.34M	$ -17.52M
Total Liabilities	$ 157.33M	$ 153.22M	$ 141.31M	$ 77.98M	$ 53.77M
Stockholders' Equity	$ -131.19M	$ -109.18M	$ -58.00M	$ 6.12M	$ 69.61M
Cash Flow
Free Cash Flow	$ -44.91M	$ -43.45M	$ -68.24M	$ -59.99M	$ -47.29M
Operating Cash Flow	$ -44.85M	$ -43.43M	$ -67.96M	$ -59.54M	$ -46.66M
Investing Cash Flow	$ 27.29M	$ 23.99M	$ 5.24M	$ 36.55M	$ -27.82M
Financing Cash Flow	$ 31.50M	$ 3.89M	$ 66.71M	$ 20.51M	$ 78.03M

Currency in USD

Galera Therapeutics Earnings and Revenue History

Income Statement >

Galera Therapeutics Debt to Assets

Balance Sheet >

Galera Therapeutics Cash Flow

Cash Flow >

Galera Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing